{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:51:58Z","timestamp":1787064718682,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00428-022-03451-z","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T06:02:59Z","timestamp":1668232979000},"page":"625-633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature"],"prefix":"10.1007","volume":"482","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7968-1846","authenticated-orcid":false,"given":"Laurence A.","family":"Galea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Witkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Hanegbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"3451_CR1","unstructured":"Amin MB, Berney DM, Comp\u00e9rat, EM, et al. Tumours of the kidney. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2022\/8\/6]. (WHO classification of tumours series, 5th\u00a0ed.; vol.\u00a08). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/36."},{"key":"3451_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig S, Ellermann J, Walther T, Burkhardt P, Fr\u00f6hlich M, Hutter B, Toprak UH, Neumann O, Stenzinger A, Scholl C, Fr\u00f6hling S, Brors B (2021) Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res 31:448\u2013460. https:\/\/doi.org\/10.1101\/gr.257246.119","journal-title":"Genome Res"},{"key":"3451_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.267.5196.316-b","volume":"267","author":"SW Morris","year":"1995","unstructured":"Morris SW, Kirstein MN, Valentine MB, Dittmer K, Shapiro DN, Look AT, Saltman DL (1995) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science 267:316\u2013317. https:\/\/doi.org\/10.1126\/science.267.5196.316-b","journal-title":"Science"},{"key":"3451_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2174\/187152007784111340","volume":"7","author":"RH Gunby","year":"2007","unstructured":"Gunby RH, Sala E, Tartari CJ, Puttini M, Gambacorti-Passerini C, Mologni L (2007) Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy. Anticancer Agents Med Chem 7:594\u2013611. https:\/\/doi.org\/10.2174\/187152007784111340","journal-title":"Anticancer Agents Med Chem"},{"key":"3451_CR5","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","volume":"33","author":"N Kuroda","year":"2020","unstructured":"Kuroda N, Trpkov K, Gao Y, Tretiakova M, Liu YJ, Ulamec M, Takeuchi K, Agaimy A, Przybycin C, Magi-Galluzzi C, Fushimi S, Kojima F, Sibony M, Hang JF, Pan CC, Yilmaz A, Siadat F, Sugawara E, Just PA, Ptakova N, Hes O (2020) ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217. Mod Pathol 33:2564\u20132579. https:\/\/doi.org\/10.1038\/s41379-020-0578-0","journal-title":"Mod Pathol"},{"key":"3451_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.18.00185","volume":"2","author":"JJ Tao","year":"2018","unstructured":"Tao JJ, Wei G, Patel R, Fagan P, Hao X, Bridge JA, Arcila ME, Al-Ahmadie H, Lee CH, Li G, Drilon A (2018) ALK fusions in renal cell carcinoma: response to entrectinib. JCO Precis Oncol 2:1\u20138. https:\/\/doi.org\/10.1200\/PO.18.00185","journal-title":"JCO Precis Oncol"},{"key":"3451_CR7","doi-asserted-by":"publisher","first-page":"152651","DOI":"10.1016\/j.prp.2019.152651","volume":"215","author":"XT Wang","year":"2019","unstructured":"Wang XT, Fang R, Ye SB, Zhang RS, Li R, Wang X, Ji RH, Lu ZF, Ma HH, Zhou XJ, Xia QY, Rao Q (2019) Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: a unique case from an older patient without clinical evidence of sickle cell trait. Pathol Res Pract 215:152651. https:\/\/doi.org\/10.1016\/j.prp.2019.152651","journal-title":"Pathol Res Pract"},{"key":"3451_CR8","doi-asserted-by":"crossref","unstructured":"Sangoi AR, Kimm SY, Chan E. VCL-ALK renal cell carcinoma in adult patient without sickle cell trait (2021) Human Pathology: Case Reports 25:200528","DOI":"10.1016\/j.ehpc.2021.200528"},{"key":"3451_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/modpathol.2010.213","volume":"24","author":"LV Debelenko","year":"2011","unstructured":"Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA (2011) Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 24:430\u2013442. https:\/\/doi.org\/10.1038\/modpathol.2010.213","journal-title":"Mod Pathol"},{"key":"3451_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/gcc.20839","volume":"50","author":"A Mari\u00f1o-Enr\u00edquez","year":"2011","unstructured":"Mari\u00f1o-Enr\u00edquez A, Ou WB, Weldon CB, Fletcher JA, P\u00e9rez-Atayde AR (2011) ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer 50:146\u2013153. https:\/\/doi.org\/10.1002\/gcc.20839","journal-title":"Genes Chromosomes Cancer"},{"key":"3451_CR11","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1002\/cncr.27391","volume":"118","author":"E Sugawara","year":"2012","unstructured":"Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K (2012) Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 118:4427\u20134436. https:\/\/doi.org\/10.1002\/cncr.27391","journal-title":"Cancer"},{"key":"3451_CR12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","volume":"38","author":"NE Smith","year":"2014","unstructured":"Smith NE, Deyrup AT, Mari\u00f1o-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P (2014) VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol 38:858\u2013863. https:\/\/doi.org\/10.1097\/PAS.0000000000000179","journal-title":"Am J Surg Pathol"},{"key":"3451_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.prp.2016.07.004","volume":"212","author":"PS Thorner","year":"2016","unstructured":"Thorner PS, Shago M, Marrano P, Shaikh F, Somers GR (2016) TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation. Pathol Res Pract 212:937\u2013942. https:\/\/doi.org\/10.1016\/j.prp.2016.07.004","journal-title":"Pathol Res Pract"},{"key":"3451_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/PAS.0000000000000610","volume":"40","author":"H Kusano","year":"2016","unstructured":"Kusano H, Togashi Y, Akiba J, Moriya F, Baba K, Matsuzaki N, Yuba Y, Shiraishi Y, Kanamaru H, Kuroda N, Sakata S, Takeuchi K, Yano H (2016) Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene. Am J Surg Pathol 40:761\u2013769. https:\/\/doi.org\/10.1097\/PAS.0000000000000610","journal-title":"Am J Surg Pathol"},{"key":"3451_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/gcc.22346","volume":"55","author":"MM Cajaiba","year":"2016","unstructured":"Cajaiba MM, Jennings LJ, Rohan SM, Perez-Atayde AR, Marino-Enriquez A, Fletcher JA, Geller JI, Leuer KM, Bridge JA, Perlman EJ (2016) ALK-rearranged renal cell carcinomas in children. Genes Chromosomes Cancer 55:442\u2013451. https:\/\/doi.org\/10.1002\/gcc.22346","journal-title":"Genes Chromosomes Cancer"},{"key":"3451_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/gcc.22382","volume":"55","author":"MM Cajaiba","year":"2016","unstructured":"Cajaiba MM, Jennings LJ, George D, Perlman EJ (2016) Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: identification of a novel HOOK1-ALK fusion transcript. Genes Chromosomes Cancer 55:814\u2013817. https:\/\/doi.org\/10.1002\/gcc.22382","journal-title":"Genes Chromosomes Cancer"},{"key":"3451_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/his.13185","volume":"71","author":"W Yu","year":"2017","unstructured":"Yu W, Wang Y, Jiang Y, Zhang W, Li Y (2017) Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review. Histopathology 71:53\u201362. https:\/\/doi.org\/10.1111\/his.13185","journal-title":"Histopathology"},{"key":"3451_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1634\/theoncologist.2016-0488","volume":"22","author":"JS Ross","year":"2017","unstructured":"Ross JS, Ali SM, Fasan O, Block J, Pal S, Elvin JA, Schrock AB, Suh J, Nozad S, Kim S, Jeong Lee H, Sheehan CE, Jones DM, Vergilio JA, Ramkissoon S, Severson E, Daniel S, Fabrizio D, Frampton G, Miller VA, Stephens PJ, Gay LM (2017) ALK fusions in a wide variety of tumor types respond to anti-ALK targeted therapy. Oncologist 22:1444\u20131450. https:\/\/doi.org\/10.1634\/theoncologist.2016-0488","journal-title":"Oncologist"},{"key":"3451_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cancergen.2017.11.010","volume":"221","author":"Y Bodokh","year":"2018","unstructured":"Bodokh Y, Ambrosetti D, Kubiniek V, Tibi B, Durand M, Amiel J, Pertuit M, Barlier A, Pedeutour F (2018) ALK-TPM3 rearrangement in adult renal cell carcinoma: report of a new case showing loss of chromosome 3 and literature review. Cancer Genet 221:31\u201337. https:\/\/doi.org\/10.1016\/j.cancergen.2017.11.010","journal-title":"Cancer Genet"},{"key":"3451_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2018.03.032","volume":"74","author":"SK Pal","year":"2018","unstructured":"Pal SK, Bergerot P, Dizman N, Bergerot C, Adashek J, Madison R, Chung JH, Ali SM, Jones JO, Salgia R (2018) Responses to alectinib in ALK-rearranged papillary renal cell carcinoma. Eur Urol 74:124\u2013128. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.032","journal-title":"Eur Urol"},{"issue":"14","key":"3451_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13000-019-0879-0","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang J, Dong L, Du H, Li XB, Liang YX, Liu GR (2019) ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review. Diagn Pathol 18(14):112. https:\/\/doi.org\/10.1186\/s13000-019-0879-0","journal-title":"Diagn Pathol"},{"key":"3451_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00428-020-02752-5","volume":"476","author":"JF Hang","year":"2020","unstructured":"Hang JF, Chung HJ, Pan CC (2020) ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology. Virchows Arch 476:921\u2013929. https:\/\/doi.org\/10.1007\/s00428-020-02752-5","journal-title":"Virchows Arch"},{"key":"3451_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3349\/ymj.2020.61.3.262","volume":"61","author":"CG Woo","year":"2020","unstructured":"Woo CG, Yun SJ, Son SM, Lim YH, Lee OJ (2020) Characteristics of renal cell carcinoma harboring TPM3-ALK fusion. Yonsei Med J 61:262\u2013266. https:\/\/doi.org\/10.3349\/ymj.2020.61.3.262","journal-title":"Yonsei Med J"},{"key":"3451_CR24","doi-asserted-by":"publisher","first-page":"153286","DOI":"10.1016\/j.prp.2020.153286","volume":"216","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Liu N, Guo W, Pu X, Guo H, Gan W, Li D (2020) ALK rearrangement in TFE3-positive renal cell carcinoma: alternative diagnostic option to exclude Xp11.2 translocation carcinoma. Pathol Res Pract 216:153286. https:\/\/doi.org\/10.1016\/j.prp.2020.153286","journal-title":"Pathol Res Pract"},{"key":"3451_CR25","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1177\/10668969211003660","volume":"29","author":"S Wangsiricharoen","year":"2021","unstructured":"Wangsiricharoen S, Zhong M, Ranganathan S, Matoso A, Argani P (2021) ALK-rearranged renal cell carcinoma (RCC): a report of 2 cases and review of the literature emphasizing the distinction between VCL-ALK and non-VCL-ALK RCC. Int J Surg Pathol 29:808\u2013814. https:\/\/doi.org\/10.1177\/10668969211003660","journal-title":"Int J Surg Pathol"},{"key":"3451_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13000-022-01238-z","volume":"17","author":"K Kai","year":"2022","unstructured":"Kai K, Tobu S, Kido S, Mikami S, Takeuchi K, Dobashi A, Togashi Y, Noguchi M, Aishima S (2022) ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report. Diagn Pathol 17:52. https:\/\/doi.org\/10.1186\/s13000-022-01238-z","journal-title":"Diagn Pathol"},{"key":"3451_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5858\/arpa.2017-0388-CP","volume":"142","author":"NI Lindeman","year":"2018","unstructured":"Lindeman NI, Cagle PT, Aisner DL et al (2018) Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Arch Pathol Lab Med 142:321\u2013346. https:\/\/doi.org\/10.5858\/arpa.2017-0388-CP","journal-title":"Arch Pathol Lab Med"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03451-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03451-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03451-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T06:05:39Z","timestamp":1679465139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03451-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3451"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03451-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient and is recorded in the patient\u2019s electronic medical record.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}